Evicenter
P&T meetings

Azetukalner (XEN1101)

Focal onset seizures

Regulatory submission
NDA submitted September 2026
Launch
Not announced
Last updated
163 sources

Product information and disease descriptionProduct descriptionProduct information

Average sales price and wholesale acquisition cost

4 evidence topics · 4 sources

Announced price for azetukalner

No evidence found.

Branded adjunctive antiseizure medication comparators: United States National Average Drug Acquisition Cost, week of 16 September 2026
Product and strengthQuoted record descriptionQuoted acquisition cost per unitQuoted effective date
Cenobamate 200 mg tablet“XCOPRI 200 MG TABLET”“39.86819”“2026-08-19”
Brivaracetam 100 mg tablet“BRIVIACT 100 MG TABLET”“24.07624”“2026-08-19”
Perampanel 12 mg tablet“FYCOMPA 12 MG TABLET”“39.07764”“2026-08-19”